Oral and intrauterine progestogens for atypical endometrial hyperplasia-Reference-Cited by-同舟云学术

Oral and intrauterine progestogens for atypical endometrial hyperplasia

Published:2018-12-04 Issue:12 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Luo Li¹²,Luo Bing³,Zheng Ying¹²,Zhang Heng¹²,Li Jing⁴,Sidell Neil⁵

Affiliation:

1. West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; No. 20, Section Three, Ren Min Nan Lu Avenue Chengdu Sichuan China 610041

2. Ministry of Education; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University); Chengdu China

3. Chengdu Women and Children Central Hospital; Department of Obstetrics and Gynecology; No.1617, Ri Yue Street Chengdu Sichuan China 610091

4. West China Hospital, Sichuan University; Chinese Cochrane Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

5. Emory University School of Medicine; Department of Gynecology and Obstetrics; 1639 Pierce Drive Atlanta USA WMB 4303 Atlanta

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009458.pub3/epdf/full

Reference28 articles.

1. Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial;Ørbo;BJOG,2014

2. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review;Buttini MJ;The Australian & New Zealand Journal of Obstetrics & Gynaecology,2009

3. The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women;Lee;Journal of Gynecologic Oncology,2010

4. Fertility-sparing treatment of early endometrial cancer and complex atypical hyperplasia in young women of childbearing potential;Pronin;International Journal of Gynecological Cancer,2015

5. The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding;Vilos;Journal of Minimally Invasive Gynecology,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcomes of infertile women with endometrial hyperplasia undergoing their first IVF/ICSI cycle: A matched-pair study;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-11

2. A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia;Journal of Assisted Reproduction and Genetics;2024-08-31

3. Comparative effects of different treatments based on the levonorgestrel intrauterine system in endometrial carcinoma and endometrial hyperplasia patients: a network meta-analysis;Archives of Gynecology and Obstetrics;2024-07-09

4. Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia – Multicenter retrospective study (KGOG2033);Gynecologic Oncology;2024-04

5. Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis;JNCI: Journal of the National Cancer Institute;2024-02-01